“It’s tough to watch everybody get sick,” she adds. “You live in constant worry.” ...

Learn more about Huntington's Disease, what causes it, and how close science is coming to finding effective treatments.

Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than treatments—now in clinical trials—that target the whole protein but leave this ...

SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) today announced interim results from the ongoing open-label KINECT ®-HD2 study about INGREZZA ® (valbenazine) ...

SAN DIEGO -- Treatment with investigational pridopidine seemed to offer benefits for certain patients with Huntington's disease, according to subgroup analysis of the PROOF-HD trial. Those ...

A new medical trial showed promising results as scientists seek a breakthrough to treat Huntington's disease, according to research team based in the United Kingdom. The clinical drug trial by ...

It turns out those everyday arm movements might carry a lot of information about HD. A new study suggests that a wrist-worn ...

In 2025, nonprofits, charities and service organizations are navigating an economy in crisis and political machinations that often put their budgets and, sometimes, their very existence in peril. And ...

Beta-blocker use was tied with slower symptom progression in people with early motor-manifest Huntington's disease. In a people with genetically confirmed premanifest Huntington's, beta-blocker use ...

The breaks at the Huntington’s Disease Therapeutics Conference are a great way to thaw out in CA’s February sunshine, take in the beautiful mountain views of Palm Springs, and network with ~450 ...

SAN DIEGO, Oct. 6, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) today presented new data from the open-label KINECT ®-HD2 study demonstrating an established long-term safety ...